Cargando…

APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia

Primary hypercholesterolemia is characterized by elevated LDL-cholesterol (LDL-C) levels isolated in autosomal dominant hypercholesterolemia (ADH) or associated with elevated triglyceride levels in familial combined hyperlipidemia (FCHL). Rare APOE variants are known in ADH and FCHL. We explored the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abou Khalil, Yara, Marmontel, Oriane, Ferrières, Jean, Paillard, François, Yelnik, Cécile, Carreau, Valérie, Charrière, Sybil, Bruckert, Eric, Gallo, Antonio, Giral, Philippe, Philippi, Anne, Bluteau, Olivier, Boileau, Catherine, Abifadel, Marianne, Di-Filippo, Mathilde, Carrié, Alain, Rabès, Jean-Pierre, Varret, Mathilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145810/ https://www.ncbi.nlm.nih.gov/pubmed/35628605 http://dx.doi.org/10.3390/ijms23105792

Ejemplares similares

Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia
por: Ghaleb, Youmna, et al.
Publicado: (2022)

Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren
por: Azar, Yara, et al.
Publicado: (2022)

Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France
por: Marduel, Marie, et al.
Publicado: (2010)

New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia
por: Elbitar, Sandy, et al.
Publicado: (2018)

Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)
por: Georges, Amandine, et al.
Publicado: (2011)

Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon
por: Ayoub, Carine, et al.
Publicado: (2022)

Identification of a Variant in APOB Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese Families
por: Ayoub, Carine, et al.
Publicado: (2021)

Genetic Testing in Familial Hypercholesterolemia: Strengthening the Tools, Reinforcing Efforts, and Diagnosis
por: Abifadel, Marianne S., et al.
Publicado: (2021)

Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
por: Di Filippo, Mathilde, et al.
Publicado: (2014)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Genetic and molecular architecture of familial hypercholesterolemia
por: Abifadel, Marianne, et al.
Publicado: (2022)

Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis
por: Matta, Anthony, et al.
Publicado: (2021)

Efficacy of daratumumab in refractory primary Sjögren disease
por: Nocturne, Gaetane, et al.
Publicado: (2023)

Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
por: Ferrières, Jean, et al.
Publicado: (2023)

Ineffective Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Monotherapy in Dyslipidemia with Low-Density Lipoprotein Cholesterol (LDL-C) Receptor Abnormalities: A Report of 2 Cases
por: Matta, Anthony, et al.
Publicado: (2020)

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
por: Ferrières, Jean, et al.
Publicado: (2022)

APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study
por: de Freitas, Rossana Ghessa Andrade, et al.
Publicado: (2015)

Association of DNA methylation and genetic variations of the APOE gene with the risk of diabetic dyslipidemia
por: Ereqat, Suheir, et al.
Publicado: (2022)

Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
por: Jelassi, Awatef, et al.
Publicado: (2013)

Prevalence and management of hypercholesterolemia in France, the Esteban observational study
por: Blacher, Jacques, et al.
Publicado: (2020)

Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study
por: Alkerwi, Ala’a, et al.
Publicado: (2013)

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
por: Gallo, Antonio, et al.
Publicado: (2021)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Dyslipidemia causes overestimation of plasma mitotane measurements
por: Paci, Angelo, et al.
Publicado: (2016)

Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia
por: Cuerq, Charlotte, et al.
Publicado: (2016)

APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study
por: Stoykovich, Seth, et al.
Publicado: (2019)

Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia
por: Fan, Lin, et al.
Publicado: (2021)

Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
por: Cariou, Bertrand, et al.
Publicado: (2011)

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody
por: Hopkins, Paul N., et al.
Publicado: (2015)

An Essential Role for Diet in Exercise-Mediated Protection against Dyslipidemia, Inflammation and Atherosclerosis in ApoE-/- Mice
por: Cesar, Liliana, et al.
Publicado: (2011)

Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm
por: Elbitar, Sandy, et al.
Publicado: (2020)

DspA/E Contributes to Apoplastic Accumulation of ROS in Non-host A. thaliana
por: Launay, Alban, et al.
Publicado: (2016)

TGFB2 loss of function mutations cause familial thoracic aortic aneurysms and acute aortic dissections associated with mild systemic features of the Marfan syndrome
por: Boileau, Catherine, et al.
Publicado: (2012)

Modulation of Dyslipidemia Markers Apo B/Apo A and Triglycerides/HDL-Cholesterol Ratios by Low-Carbohydrate High-Fat Diet in a Rat Model of Metabolic Syndrome
por: Alnami, Abrar, et al.
Publicado: (2022)

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
por: van Eenige, Robin, et al.
Publicado: (2021)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Accuracy of the ankle-brachial index using the SCVL(®), an arm and ankle automated device with synchronized cuffs, in a population with increased cardiovascular risk
por: Rosenbaum, David, et al.
Publicado: (2012)

Les incas : ou, la destruction de l'empire du Pérou
por: Marmontel, Jean-Francois, 1723-1799
Publicado: (1851)

APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants
por: Vanhoye, Xavier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekt5vbisl7csae1dtgutof7f10